Man Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Hold
0
– -$3.5M – 2033
2023
Q3
– Hold
0
– – – 996

Other funds holding XBI

Man Group's XBI Position: Q3 2026 in Review

Man Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, closing a stake of 35,717 shares — an estimated $5.65M sold.

Man Group first reported a position in XBI in Q2 2018 and held it in 7 quarters. The position peaked at $8.99M in Q4 2023. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Man Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2026 after selling out during the quarter.
  • Man Group sold 35,717 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $5.65M.
  • Man Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 7 quarters.
  • Man Group's State Street SPDR S&P Biotech ETF position peaked at $8.99M in Q4 2023.
  • 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Man Group's 13F filing for Q3 2026, filed 16 Nov 2026.